Most of us use Google every day to search for information so why not use our network of consultants to ïFish for Knowledge. Bioscientifix provides consultancy services from a network of specialists covering a wide range of expertise to the chemical, biotechnology and medical diagnostics industries. The increasing complexity of industry and the way these industries overlap requires a wide-ranging skill set to advise and solve problems. Our experts have experience in industry and academia and have themselves developed novel technologies and have an impressive list of patent filings.
Bioscientifix can provide advice from specialists covering:-
Laboratory synthesis and production scale up of synthetic polymers, oligonucleotides, peptides and bio-molecular conjugates.
Advice and strategy for inventors and investors wishing to commercialise products in the chemical, pharmaceutical, biotechnology and medical diagnostics industries.
Technology transfer from academia to industry.
Technology advice to the board of a company.
Intellectual Property Rights (IPR) _ advice, due diligence and protection.
Innovation, new product strategy and development and proof-of-concept.
Start-up company formation, management support and funding.
Innovation, new product strategy and development.
ChemopetLLP provides both a consultancy service and dispensing pharmacy assisting vets nationally to treat patients (mainly cats and dogs), with cancer. Individual doses of chemotherapy are delivered by next day courier to surgeries for administration, eliminating stocking and handling concerns.
Custom synthesis and purification: SpheriTech specialises in consultancy and laboratory based contract R&D supporting a range of industries including peptide synthesis, oligonucleotide synthesis, polymer synthesis, biocatalysis, cell culture and all aspects of chromatography. The company also offers custom synthesis of peptides, small molecules, enzyme immobilization and contract purification of any molecule, small or large. SpheriTech has a portfolio of intellectual property covering a diverse platform of technologies including peptide synthesis, DNA synthesis, polymer synthesis, biocatalysis, cell culture and chromatography
Our mission is to collaboratively leverage existing cutting-edge technological innovations to improve the quality of life and survival of cancer patients by our work in clinical and pre-clinical stages of cancer therapies.
Our vision is to provide every cancer patient with our specialised diagnostic test to Personalised Therapy leading to improved quality of life and overall survival backed by reliable clinical trials.
We will be committed to provide accurate, reliable, validated laboratory results to guide the Personalised Therapy for the Cancer patient.